142 related articles for article (PubMed ID: 8079343)
1. Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity.
Hanslik T; Blanchet F; Nochy D; Pirotzky E; Guilmard C; Seta N; Carbon C
Toxicol Appl Pharmacol; 1994 Sep; 128(1):111-5. PubMed ID: 8079343
[TBL] [Abstract][Full Text] [Related]
2. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
Rodriguez-Barbero A; López-Novoa JM; Arévalo M
Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity.
Dos Santos OF; Boim MA; Barros EJ; Schor N
Kidney Int; 1991 Oct; 40(4):742-7. PubMed ID: 1745025
[TBL] [Abstract][Full Text] [Related]
4. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
5. Role of platelet activating factor in kidney transplant rejection in the rat.
Butterly DW; Spurney RF; Ruiz P; Pirotzky E; Braquet P; Coffman TM
Kidney Int; 1995 Aug; 48(2):337-43. PubMed ID: 7564100
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.
Hirashima Y; Endo S; Otsuji T; Karasawa K; Nojima S; Takaku A
J Neurosurg; 1993 Apr; 78(4):592-7. PubMed ID: 8450333
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin activates rat mesangial cells. A role for platelet activating factor.
Rodriguez-Barbero A; Rodriguez-Lopez AM; Gonzalez-Sarmiento R; López-Novoa JM
Kidney Int; 1995 May; 47(5):1346-53. PubMed ID: 7637264
[TBL] [Abstract][Full Text] [Related]
10. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
De Kimpe SJ; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
[TBL] [Abstract][Full Text] [Related]
11. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D
J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury.
Plante GE; Sirois P; Braquet P
Prostaglandins Leukot Essent Fatty Acids; 1988 Oct; 34(1):53-60. PubMed ID: 3231663
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of PAF-acether on the dog kidney.
Hébert RL; Sirois P; Braquet P; Plante GE
Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688
[TBL] [Abstract][Full Text] [Related]
16. [The role of platelet activating factor in mesenterioangial microcirculatory disturbance complicated with acute pancreatitis in rats].
Ji Z; Wang B; Li S
Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):139-40, 188. PubMed ID: 7780816
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
[TBL] [Abstract][Full Text] [Related]
18. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization.
Cohen RA; Gebhardt BM; Bazan NG
Curr Eye Res; 1994 Feb; 13(2):139-44. PubMed ID: 8194360
[TBL] [Abstract][Full Text] [Related]
19. Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats.
Grypioti AD; Theocharis SE; Demopoulos CA; Papadopoulou-Daifoti Z; Basayiannis AC; Mykoniatis MG
Liver Int; 2006 Feb; 26(1):97-105. PubMed ID: 16420515
[TBL] [Abstract][Full Text] [Related]
20. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Liu BJ; Zhang HT; Zheng MR
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
